The birth control drugs Yaz, Yasmin and Ocella are facing increasing litigation citing some serious complications. According to the San Francisco Chronicle, a recent study listed Yaz and Yasmin as the second worst drugs on the market for adverse events. Between Yaz and Yasmin alone, over 8,000 adverse side effects…
On June 8th, the Texas Supreme Court issued a ruling on the Centocor, Inc. v. Hamilton case. This case concerns Remicade, a drug used to treat Crohn’s disease, which is manufactured by Centocor, Inc, a subsidiary of Johnson & Johnson. The plaintiff argued that she developed a very serious syndrome…
Pradaxa is a new blood thinning drug touted as an alternative to the traditional (and problematic) warfarin, a drug in use since the 1950’s. It is an oral treatment that has been approved in preventing strokes in patients who suffer from atrial fibrillation, an irregular heartbeat. Pradaxa’s main goal is…
Actos, an oral diabetes drug produced by Takeda Pharmaceuticals, may increase the risk of developing bladder cancer. Several studies have noted a connection between high and long-term doses of Actos and prevalence of bladder cancer. There have recently been many lawsuits filed seeking redress for physical and mental distress caused…
The Senate has recently passed a bill that would require greater oversight of drug manufacturing facilities overseas. This bill is concerned with increasing the safety and quality of imported medicine. The FDA is responsible for inspecting all U.S. drug manufacturers, but it has failed to account for the complexities of…
Recent reports have shown that the FDA is stepping up in strengthening the approval and research of post-approval drug safety. The administration has created a post market drug safety program that has shown to be extremely effective. The Center for Drug Evaluation and Research (CDER), the administration’s program, focuses on…
Bayer, a world-wide pharmaceutical company headquartered in Leverkusen, Germany, has agreed to pay an average of $220,000 per case to settle close to 500 law suits involving Yaz and Yasmin. The once very popular contraceptive pills have now gained negative attention across the world. Yaz and Yasmin, unlike older birth…
Yaz, Yasmin and several other newer birth controls will soon undergo important changes to their labeling. Last Tuesday the FDA announced the changes will take place immediately in order to properly inform the public about the slight increased risk in thromboembolism, the formation of blood clots, while taking the once-a-day…
A recent study suggests a possible link between an increased risk in cancer or even death with the use of sleeping pills. Statistics show that an estimated six to ten percent of Americans currently take sleeping pills, a number that continues to increase as the public is provided with numerous…
Just recently Bayer Healthcare has reported the pharmaceutical company has reached agreements to settle all Yaz and Yasmin lawsuits brought by at least 70 women. In 2006, Bayer launched the very popular Yaz birth control, a once a day contraceptive pill that also helped women with acne and PMS symptoms.…